Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07789106
What this trial is testing

A Study on Ubiquinol on Fatigue and Muscle Strength in Healthy Adults Taking GLP-1 Agonists

Who this might be right for
Obesity & OverweightGLP - 1Fatigue Severity Scale+2 more
StudySetGo 90
Early research (Phase 1)Study completedNCT01866748
What this trial is testing

Investigation on Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of a Long-acting GLP-1 Analogue (Semaglutide) in an Oral Formulation in Healthy Male Subjects

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Healthy
Novo Nordisk A/S 170
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06180616
What this trial is testing

Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity

Who this might be right for
Type 1 Diabetes MellitusOverweight and Obesity
Royal North Shore Hospital 40
Not applicableActive Not RecruitingNCT06715514
What this trial is testing

Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes

Who this might be right for
MenopauseType 2 Diabetes
Lia Bally 96
Not applicableStudy completedNCT01162499
What this trial is testing

Role of Glucagon-Like Peptide-1 in Postprandial Hypoglycemia

Who this might be right for
Postprandial Hypoglycemia
Diva De Leon 7
Large-scale testing (Phase 3)Study completedNCT05260021
What this trial is testing

Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both

Who this might be right for
Type2 DiabetesDiabetes MellitusDiabetes Mellitus, Type 2+5 more
Eli Lilly and Company 99
Not applicableStudy completedNCT05078255
What this trial is testing

The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients with Type 2 Diabetes

Who this might be right for
Type 2 DiabetesObesity
Asger Lund, MD 61
Early research (Phase 1)Study completedNCT01218633
What this trial is testing

Dose-response Study of Exendin-9,39 on Glucose Metabolism

Who this might be right for
Pancreatic Effects of 9,39-Exendin and 9,36-GLP-1
Adrian Vella 11
Not applicableLooking for participantsNCT07293325
What this trial is testing

Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity

Who this might be right for
Adults With Simple Obesity
Second Affiliated Hospital, Zhejiang University, School of Medicine 66
Not applicableLooking for participantsNCT07226947
What this trial is testing

Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment

Who this might be right for
ObesityBody Composition
Massachusetts General Hospital 100
Early research (Phase 1)Study completedNCT01721382
What this trial is testing

Treatment of Dysglycemia Using Sitagliptin in Adolescents With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Nemours Children's Clinic 6
Early research (Phase 1)Study completedNCT00971659
What this trial is testing

Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Profil Institut für Stoffwechselforschung GmbH 48
Not applicableWithdrawnNCT04643301
What this trial is testing

Liraglutide for Low-responders After Bariatric Surgery

Who this might be right for
ObesityObesity, Morbid
Zuyderland Medisch Centrum
Early research (Phase 1)Study completedNCT00393445
What this trial is testing

Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans

Who this might be right for
Hyperglycemia
Ludwig-Maximilians - University of Munich 6
Post-approval studies (Phase 4)Study completedNCT01755572
What this trial is testing

Blood Pressure Outcomes With Liraglutide Therapy

Who this might be right for
Type 2 DiabetesSystolic Hypertension
Mount Sinai Hospital, Canada 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07314528
What this trial is testing

Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer

Who this might be right for
Rectal Cancer PatientsObesity &Amp; OverweightLocally Advanced Rectal Cancer (LARC)+2 more
St. James's Hospital, Ireland 42
Testing effectiveness (Phase 2)Looking for participantsNCT05938712
What this trial is testing

The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Recipients
University Health Network, Toronto 20
Early research (Phase 1)Study completedNCT00537719
What this trial is testing

Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 34
Early research (Phase 1)Study completedNCT05377333
What this trial is testing

LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 94
Post-approval studies (Phase 4)Study completedNCT05706506
What this trial is testing

Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)

Who this might be right for
Type 2 DiabetesDiabetes Mellitus, Type 2
Eli Lilly and Company 152
Next Page